Delivery Order SPE2DB22D9330-SPE2DB24FK8MN

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,896.90, is for the delivery of 0.5 ML CAPVAXIVE syringes to support the recurring medical supply needs of military healthcare facilities. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
This is a Firm Fixed Price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,479.47 award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to provide a variety of pharmaceutical products to support military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,628 contract is for the delivery of meningococcal group vaccines and medical supplies, with a period of performance through June 2025. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,126.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of January 2, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award, valued at $1,548.35, is for the provision of pharmaceutical products and medical supplies to support U.S. military healthcare facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4567552552 YF-VAX 1 dose vials and has an ultimate completion date of March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,634.04, is for the provision of pharmaceutical products, including syringes, tablets, injections, creams, and specialty medications, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $18,526.83 and an ultimate completion date of August 7, 2024. This award is under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm...
  • SPE2DB22D9330
    Indefinite Delivery Contract
  • SPE2DB22D9330-SPE2DB24FK8MN
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,981.11 award is for the delivery of 4565691711 CAPVAXIVE 0.5 ML SYRINGE 0.5ML medical supplies, with a completion date of September 4, 2024.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. As a prime vendor for the DLA, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 12/3/24, 10:08 AM